ITMI20031302A1 - Uso di etanolo come plasticizzante per preparare impianti sottocutanei contenenti principi attivi termolabili dispersi in una matrice di plga. - Google Patents

Uso di etanolo come plasticizzante per preparare impianti sottocutanei contenenti principi attivi termolabili dispersi in una matrice di plga.

Info

Publication number
ITMI20031302A1
ITMI20031302A1 IT001302A ITMI20031302A ITMI20031302A1 IT MI20031302 A1 ITMI20031302 A1 IT MI20031302A1 IT 001302 A IT001302 A IT 001302A IT MI20031302 A ITMI20031302 A IT MI20031302A IT MI20031302 A1 ITMI20031302 A1 IT MI20031302A1
Authority
IT
Italy
Prior art keywords
ethanol
thermalable
plasticizer
implants containing
subcutaneous implants
Prior art date
Application number
IT001302A
Other languages
English (en)
Italian (it)
Inventor
Pierre Marion
Patrice Mauriac
Original Assignee
Mediolanum Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mediolanum Pharmaceuticals Ltd filed Critical Mediolanum Pharmaceuticals Ltd
Priority to IT001302A priority Critical patent/ITMI20031302A1/it
Publication of ITMI20031302A0 publication Critical patent/ITMI20031302A0/it
Priority to ES04741884T priority patent/ES2308195T3/es
Priority to HK06110518.6A priority patent/HK1089954B/en
Priority to MXPA05013697A priority patent/MXPA05013697A/es
Priority to US10/562,707 priority patent/US8206621B2/en
Priority to EP04741884A priority patent/EP1638534B1/en
Priority to PCT/EP2004/051226 priority patent/WO2005000277A1/en
Priority to AU2004251456A priority patent/AU2004251456B2/en
Priority to AT04741884T priority patent/ATE398447T1/de
Priority to PT04741884T priority patent/PT1638534E/pt
Priority to CNB2004800177773A priority patent/CN100509060C/zh
Priority to DE602004014496T priority patent/DE602004014496D1/de
Priority to JP2006516183A priority patent/JP2009513165A/ja
Priority to PL04741884T priority patent/PL1638534T3/pl
Priority to BRPI0411759-0A priority patent/BRPI0411759A/pt
Priority to CA2530117A priority patent/CA2530117C/en
Priority to KR1020057024514A priority patent/KR101143771B1/ko
Publication of ITMI20031302A1 publication Critical patent/ITMI20031302A1/it
Priority to CY20081101000T priority patent/CY1108346T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/06—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/141—Plasticizers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Thermotherapy And Cooling Therapy Devices (AREA)
IT001302A 2003-06-26 2003-06-26 Uso di etanolo come plasticizzante per preparare impianti sottocutanei contenenti principi attivi termolabili dispersi in una matrice di plga. ITMI20031302A1 (it)

Priority Applications (18)

Application Number Priority Date Filing Date Title
IT001302A ITMI20031302A1 (it) 2003-06-26 2003-06-26 Uso di etanolo come plasticizzante per preparare impianti sottocutanei contenenti principi attivi termolabili dispersi in una matrice di plga.
KR1020057024514A KR101143771B1 (ko) 2003-06-26 2004-06-24 Ｐｌｇａ 매트릭스에 분산된 열불안정성 활성 성분을함유하는 피하 삽입물을 제조하기 위한 가소제로서에탄올의 용도
AT04741884T ATE398447T1 (de) 2003-06-26 2004-06-24 Verwendung von ethanol als weichmacher zur herstellung von subkutanen implantaten , welche in einer plga matrize dispergierte thermolabile wirkstoffe enthalten
CNB2004800177773A CN100509060C (zh) 2003-06-26 2004-06-24 乙醇作为增塑剂来制备含分散于plga基质中的不耐热有效成分的皮下植入物的用途
MXPA05013697A MXPA05013697A (es) 2003-06-26 2004-06-24 Utilizacion de etanol como plastificante para preparar implantes subcutaneos que contienen principios activos termoabiles dispersos en una matriz plga.
US10/562,707 US8206621B2 (en) 2003-06-26 2004-06-24 Use of ethanol as plasticizer for preparing subcutaneous implants containing thermolabile active principles dispersed in a PLGA matrix
EP04741884A EP1638534B1 (en) 2003-06-26 2004-06-24 Use of ethanol as plasticizer for preparing subcutaneous implants containing thermolabile active principles dispersed in a plga matrix
PCT/EP2004/051226 WO2005000277A1 (en) 2003-06-26 2004-06-24 Use of ethanol as plasticizer for preparing subcutaneous implants containing thermolabile active principles dispersed in a plga matrix
AU2004251456A AU2004251456B2 (en) 2003-06-26 2004-06-24 Use of ethanol as plasticizer for preparing subcutaneous implants containing thermolabile active principles dispersed in a PLGA matrix
ES04741884T ES2308195T3 (es) 2003-06-26 2004-06-24 Uso de etanol como plastificante para preparar implantes subcutaneos que contienen principios activos termolabiles dispersos en una matriz de plga.
PT04741884T PT1638534E (pt) 2003-06-26 2004-06-24 Uso de etanol como plastificante para preparar implantes subcutâneos contendo princípios activos termolabiais dispersados numa matriz plga
HK06110518.6A HK1089954B (en) 2003-06-26 2004-06-24 Use of ethanol as plasticizer for preparing subcutaneous implants containing thermolabile active principles dispersed in a plga matrix
DE602004014496T DE602004014496D1 (de) 2003-06-26 2004-06-24 Verwendung von ethanol als weichmacher zur herstellung von subkutanen implantaten , welche in einer plga matrize dispergierte thermolabile wirkstoffe enthalten
JP2006516183A JP2009513165A (ja) 2003-06-26 2004-06-24 Ｐｌｇａマトリックス中に分散された熱不安定性活性成分を含有する皮下インプラントを製造するための可塑剤としてのエタノールの使用
PL04741884T PL1638534T3 (pl) 2003-06-26 2004-06-24 Zastosowanie etanolu jako zmiękczacza do wytwarzania podskórnych implantów zawierających termolabilne substancje czynne rozproszone w matrycy PLGA
BRPI0411759-0A BRPI0411759A (pt) 2003-06-26 2004-06-24 uso do etanol como plastificante para preparar implantes subcutáneos contendo princìpios ativos termolábeis dispersos em uma matriz plga
CA2530117A CA2530117C (en) 2003-06-26 2004-06-24 Use of ethanol as plasticizer for preparing subcutaneous implants containing thermolabile active principles dispersed in a plga matrix
CY20081101000T CY1108346T1 (el) 2003-06-26 2008-09-17 Χρηση της αιθανολης ως πλαστικοποιητης για την προετοιμασια υποδοριων εμφυτευματων που περιεχουν θερμοευαισθητα ενεργα στοιχεια τα οποια διαλυονται σε μια μητρα plga

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT001302A ITMI20031302A1 (it) 2003-06-26 2003-06-26 Uso di etanolo come plasticizzante per preparare impianti sottocutanei contenenti principi attivi termolabili dispersi in una matrice di plga.

Publications (2)

Publication Number Publication Date
ITMI20031302A0 ITMI20031302A0 (it) 2003-06-26
ITMI20031302A1 true ITMI20031302A1 (it) 2004-12-27

Family

ID=30131301

Family Applications (1)

Application Number Title Priority Date Filing Date
IT001302A ITMI20031302A1 (it) 2003-06-26 2003-06-26 Uso di etanolo come plasticizzante per preparare impianti sottocutanei contenenti principi attivi termolabili dispersi in una matrice di plga.

Country Status (17)

Country Link
US (1) US8206621B2 (https=)
EP (1) EP1638534B1 (https=)
JP (1) JP2009513165A (https=)
KR (1) KR101143771B1 (https=)
CN (1) CN100509060C (https=)
AT (1) ATE398447T1 (https=)
AU (1) AU2004251456B2 (https=)
BR (1) BRPI0411759A (https=)
CA (1) CA2530117C (https=)
CY (1) CY1108346T1 (https=)
DE (1) DE602004014496D1 (https=)
ES (1) ES2308195T3 (https=)
IT (1) ITMI20031302A1 (https=)
MX (1) MXPA05013697A (https=)
PL (1) PL1638534T3 (https=)
PT (1) PT1638534E (https=)
WO (1) WO2005000277A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7666445B2 (en) 2000-10-20 2010-02-23 The Trustees Of The University Of Pennsylvania Polymer-based surgically implantable haloperidol delivery systems and methods for their production and use
US8329203B2 (en) 2004-01-12 2012-12-11 The Trustees Of The University Of Pennsylvania Drug-containing implants and methods of use thereof
US8221778B2 (en) 2005-01-12 2012-07-17 The Trustees Of The University Of Pennsylvania Drug-containing implants and methods of use thereof
PT1781264E (pt) 2004-08-04 2013-10-16 Evonik Corp Métodos para o fabrico de dispositivis de administração e dispositivos para a mesma
EP1909689A4 (en) * 2005-07-18 2011-11-16 Univ Pennsylvania PHARMACEUTICAL IMPLANTS AND METHOD OF USE THEREOF
ITMI20061539A1 (it) * 2006-08-02 2008-02-03 Mediolanum Pharmaceuticals Ltd Impianti sottocutanei in grado di rilasciare il principio attivo per un periodo prolungato di tempo
EP2236546B1 (en) 2006-10-31 2011-12-28 Surmodics Pharmaceuticals, Inc. Speronized polymer particles
ES2718612T3 (es) 2007-12-20 2019-07-03 Evonik Corp Procedimiento para preparar micropartículas que tienen un bajo volumen de disolvente residual
CN102281870B (zh) * 2008-12-10 2015-03-04 安徽中人科技有限责任公司 新型控释组合物
EP2590628A1 (en) * 2010-06-30 2013-05-15 Evonik Corporation Implant processing methods for thermally labile and other bioactive agents and implants prepared from same
GB201314312D0 (en) * 2013-08-09 2013-09-25 Regentec Ltd Composition and delivery system
CN103623415B (zh) * 2013-12-04 2015-03-25 北京诺康达医药科技有限公司 一种用于生物多肽制剂的plga与乙醇的复合物
EP3177319A1 (en) * 2014-08-04 2017-06-14 Janssen Sciences Ireland UC Compacted solid dosage form
GB201702475D0 (en) * 2017-02-15 2017-03-29 Locate Therapeutics Ltd Tissue scaffold and scaffold composition
ES2938608T3 (es) * 2017-09-20 2023-04-13 Tillotts Pharma Ag Método para preparar una forma farmacéutica sólida que comprende anticuerpos mediante granulación en húmedo, extrusión y esferonización

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0549629A (ja) * 1991-08-23 1993-03-02 Konica Corp 医用放射線画像読影装置
US5520923A (en) * 1994-09-19 1996-05-28 Genetics Institute, Inc. Formulations for delivery of osteogenic proteins
IT1304152B1 (it) 1998-12-10 2001-03-08 Mediolanum Farmaceutici Srl Composizioni comprendenti un peptide ed acido polilattico-glicolicoatte alla preparazione di impianti sottocutanei aventi un prolungato
NZ533434A (en) * 2001-11-14 2006-11-30 Alza Corp Thixotropic gel composition for injectable deposition

Also Published As

Publication number Publication date
CN100509060C (zh) 2009-07-08
AU2004251456B2 (en) 2009-12-03
EP1638534A1 (en) 2006-03-29
ITMI20031302A0 (it) 2003-06-26
EP1638534B1 (en) 2008-06-18
ATE398447T1 (de) 2008-07-15
CA2530117A1 (en) 2005-01-06
US20060171987A1 (en) 2006-08-03
CN1812770A (zh) 2006-08-02
WO2005000277A1 (en) 2005-01-06
AU2004251456A1 (en) 2005-01-06
ES2308195T3 (es) 2008-12-01
CA2530117C (en) 2012-01-10
JP2009513165A (ja) 2009-04-02
CY1108346T1 (el) 2014-02-12
PL1638534T3 (pl) 2009-02-27
MXPA05013697A (es) 2006-05-17
HK1089954A1 (en) 2006-12-15
BRPI0411759A (pt) 2006-08-08
US8206621B2 (en) 2012-06-26
PT1638534E (pt) 2008-09-29
KR101143771B1 (ko) 2012-05-11
DE602004014496D1 (de) 2008-07-31
KR20060079146A (ko) 2006-07-05

Similar Documents

Publication Publication Date Title
ITMI20031302A1 (it) Uso di etanolo come plasticizzante per preparare impianti sottocutanei contenenti principi attivi termolabili dispersi in una matrice di plga.
ATE244558T1 (de) Trockene formbare arzneistoffformulierung
CR7921A (es) Formulaciones farmaceuticas liquidas de palonosetron
MX2007003930A (es) Activos encapsulados de alta resistencia extensible termicamente estables.
MX2009011275A (es) Una composicion de microesferas biodegradables adecuadas para la liberacion controlada de peptido de control de la glucosa y formulacion de la misma.
AR048033A1 (es) Composicion farmaceutica para moldear componentes que comprende copolimero de poli(met)acrilato, cubierta, conector o espaciador de capsula moldeado por inyeccion que tiene la composicion farmaceutica y forma de dosificacion farmaceutica de multicomponentes a partir de dicha composicion
MY146990A (en) Film containing compositions
UY28744A1 (es) Particulados
IL174154A (en) History of GLP-1 New Pharmaceutical Preparations Containing Them and Using It to Make Medicines
BRPI0807544B8 (pt) corpo alongado para injeção parenteral livre de agulha em baixa velocidade de um dispositivo, método para fazer o referido corpo, uso do mesmo e embalagem de droga para uso com um dispositivo de distribuição de droga
NL2000281A1 (nl) Vaste farmaceutische samenstellingen die pregabaline bevatten.
DK1480624T3 (da) Farmaceutisk tablet
NO20025755D0 (no) Formulering basert på heparin, glykosaminoglykan eller heparinoid, bruk avformuleringen eller formuleringsbasen
DE502004003914D1 (de) Quellbare hydrogelbildende polymere mit geringem feinstaubanteil
BR0315657A (pt) Formulação de dosagem sólida, comprimido para liberação controlada, método de fabricar uma medicação de liberação controlada, composição farmacêutica e uso de uma composição
UY27929A1 (es) Composiciones farmaceuticas de farmacos semiordenados y polimeros
ATE386516T1 (de) Anthelmintische zusammensetzungen
DE602006016127D1 (de) Zusammensetzung und dosierform mit einer festen oder halbfesten matrix
MX2009001231A (es) Implantes subcutaneos que liberan un principio activo durante un periodo de tiempo extendido.
DE602006019320D1 (de) Biologisch wirksame zusammensetzung mit ethylcellulose
HRP20080178T3 (hr) Farmaceutski pripravak u obliku hidrogela za transdermalnu primjenu aktivnih tvari
ATE479417T1 (de) Zahnfüllmaterial
DE60303149D1 (de) Salz von morphin-6-glucuronid
TW200514571A (en) Pharmaceutical composition with improved solubility and fluidity
Zulfakar et al. Development and mechanical characterization of eugenol–cetalkonium chloride sustained release mucoadhesive oral film